Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Feb;65(2):360-1.
doi: 10.1136/gutjnl-2015-309978. Epub 2015 Jun 17.

Prevalent low-grade dysplasia: the strongest predictor of malignant progression in Barrett's columnar-lined oesophagus

Lisa H Moyes  1 , Karin A Oien  2 , Alan K Foulis  3 , Grant M Fullarton  1 , James J Going  2
Affiliations
Comment

Prevalent low-grade dysplasia: the strongest predictor of malignant progression in Barrett's columnar-lined oesophagus

Lisa H Moyes et al. Gut. 2016 Feb.
No abstract available

Keywords: ADENOCARCINOMA; BARRETT'S OESOPHAGUS; DYSPLASIA; OESOPHAGEAL DISORDERS.

PubMed Disclaimer

Figures

Figure1
Figure1
(A) Kaplan–Meier curves for malignant progression (to HGD and/or OA) in Glasgow BO cases with prevalent LGD (red curve) and without (blue). Grey shading represents 95% CI. Numbers in follow-up are given above the x axis. (B) duplicates the first 5 years of these curves and superimposes (in orange) the curve for malignant progression of LGD, validated by Duits et al in the Netherlands. The LGD curves are very close at 5 years. BO, Barrett's oesophagus; HGD, high-grade dysplasia; LGD, low-grade dysplasia; NL, Netherlands; OA, oesophageal adenocarcinoma.
See this image and copyright information in PMC

Comment on

References

    1. Duits LC, Phoa KN, Curvers WL, et al. . Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert panel. Gut 2015;64:700–6. 10.1136/gutjnl-2014-307278 - DOI - PubMed
    1. Yachimski P. What we talk about when we talk about dysplasia. Gut 2015;64:695–6. 10.1136/gutjnl-2014-307969 - DOI - PubMed
    1. Fitzgerald RC, di Pietro M, Raganuth K, et al. . British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut 2014;63:7–42. 10.1136/gutjnl-2013-305372 - DOI - PubMed
    1. Phoa KN, van Vilsteren FG, Weusten BL, et al. . Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA 2014;311:1209–17. 10.1001/jama.2014.2511 - DOI - PubMed